Innovative Pricing and Payment Models for Health Technologies

Proposed Classification

The authors propose a new classification system that is both flexible and need-driven. This system is designed to help policymakers, healthcare providers, and manufacturers navigate the complex landscape of P&P schemes more effectively. It considers various factors, including the type of health technology and the specific needs of different healthcare systems.

Key Features

The article highlights several key features of effective pricing and payment schemes, which include:

Flexibility: The ability to adapt to evolving healthcare needs and financial constraints.

Value-Based: Schemes that tie payments to actual health outcomes or to the value delivered by the health technology.

Risk Management: Mechanisms that distribute risk among manufacturers, payers, and providers.

Innovation Incentives: Schemes designed to encourage the development and adoption of new health technologies.

Implications

The proposed classification and analysis of P&P schemes have significant implications for healthcare policy, practice, and research. It can aid in:

Improving the sustainability of healthcare systems

Enhancing access to innovative health technologies

Aligning payments with health outcomes

Reducing financial uncertainty for various stakeholders involved.

In summary, the article provides a comprehensive framework for understanding and improving the design and implementation of P&P schemes in the healthcare sector, ultimately serving as a vital tool in addressing current challenges. The focus on pricing and payment schemes is essential for fostering effective health technology utilization and ensuring ongoing innovation.

Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR

June 30, 2025 Rene Pretorius

🚀 Are prior authorizations stalling care delivery in the U.S. healthcare system?

The HHS has launched an ambitious collaboration with major insurers to reform prior authorization processes across Medicare Advantage, Medicaid, and commercial plans. With a goal to standardize submissions by 2027 and significantly reduce requirements by 2026, this initiative promises to accelerate care decisions and enhance transparency.

Dive into the details of these pivotal reforms and discover their potential to streamline healthcare and improve patient outcomes.

#SyenzaNews #HealthcareInnovation #healthcare #healthcarepolicy

Private Health Funding Under South Africa’s National Health Insurance Act

June 30, 2025 João L. Carapinha

🚀 Update on NHI in South Africa.

In their insightful article, Solanki et al. discuss the complexities of private health funding amidst the nation’s National Health Insurance Act. They discuss two key scenarios: a passive approach that risks the sustainability of the private sector and an active reform strategy that could ensure a smoother transition to universal coverage.

Curious about how these strategies could reshape healthcare access and costs in South Africa? Don’t miss out on this critical analysis!

#SyenzaNews #HealthEconomics #HealthcarePolicy

Impending Net Drug Price Transparency Regulation in the U.S.

June 27, 2025June 27, 2025 Rene Pretorius

💡 Are you ready for a potential game-changer in drug pricing transparency?

CMS Administrator Mehmet Oz has hinted at a new rule aimed at enforcing stricter disclosures for drug prices, requiring healthcare companies to reveal actual transaction costs. This could reshape how price transparency is managed across the industry and challenge pharmacy benefit managers to rethink rebate practices.

Curious about how this will impact healthcare economics and what it means for drug affordability? Dive into the article for all the insights!

#SyenzaNews #healthcare #HealthEconomics